Monday, September 14, 2026

Former Ssangbangwool Vice Chairman Bang Yong-cheol Sentenced to 1 Year in Prison for “Exchange with North Korean Agent”

Former Ssangbangwool Vice Chairman Bang Yong-cheol received a suspended sentence for illicit meetings with North Korean operatives.

Tiger Research Forecasts U.S. Clarity Act Could Win Final Passage by July

The U.S. Clarity Act aims for passage by July, regulating stablecoins and enabling legal token issuance, boosting the digital asset market.

AI Breakthrough Enables Robots to Understand Complex Human Instructions in 3D Spaces

GIST researchers led by Professor Kim Eui-hwan developed Context-Nav, an AI technology enabling robots to navigate using human language.

Tag: Biotech

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

2025’s Drug Price Revolution: What Asian Pharma Firms Need to Know About MFN Policies

Trump's second term sees U.S. drug pricing reforms and supply chain shifts, prompting South Korean firms to seize new opportunities.

Unlocking Global Biotech: CGB-CIC Innovation Center Launching in 2026

CHA Bio Group partners with CIC to create a global bio-ecosystem, enhancing support for biotech firms in cell and gene therapy.

Unlocking Opportunities: Highlights from the 2026 J.P. Morgan Healthcare Conference in San Francisco

The 44th JP Morgan Healthcare Conference in San Francisco drew a large crowd of professionals in formal attire early in the morning.

Samsung Biologics Targets Japan’s $12.3 Billion CDMO Market: What You Need to Know

Samsung Biologics expands in Japan, targeting top pharma firms with new CMO brand 'ExellenS' and enhancing production capabilities.

As Wegovy and Mounjaro Soar, Korean Biotechs Seek a Slice of the Obesity Drug Market

South Korean firms are innovating in the GLP-1 obesity treatment market, developing unique drugs to compete with industry leaders.

No More Lab Rats? FDA Shift Spurs AI Boom in Drug Development

AI is transforming drug discovery in pharma, especially after the FDA's shift away from animal testing, enhancing efficiency.

Europe Moves to Ease Biosimilar Rules, Boosting Asia’s Biopharma Giants

EMA's new guidelines aim to simplify biosimilar development, boosting Samsung Bioepis and Celltrion in Europe's growing market.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.